Please login to the form below

Not currently logged in

FDA adcomm split on Sanofi’s type 1 diabetes drug

Sanofi reception

Concerns rose after Zynquista-treated patients showed an eight-fold increase in DKA

Evenity back on track with FDA panel blessing in osteoporosis

FDA headquarters White OakUS drugs regulator first rejected the drug due to cardiovascular concerns

FDA expecting boom in cell and gene therapies

FDA headquarters White OakPledges clampdown on developers working outside regulations

China approves Ironwood Pharma’s IBS treatment

Coincides with AZ's Mark Mallon taking over as CEO

Industry pleads for compromise after Brexit defeat

Brexit VotePrime Minister is more boxed in than ever, but unlikely to be toppled

Crunch time as Brexit deal faces ‘meaningful vote’

Brexit Cut OutRejecting the deal would either result in a no deal or no Brexit, warns May

FDA moves into crisis mode as shutdown drags on

Scott GottliebNew drug appraisals already being affected

Global ban on pharma freebies, including cultural gifts

New rules cover mooncakes and bereavement payments

Time running out for ‘no-deal’ Brexit medicines laws

MHRANeeds parliament clearance before 29 March

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...